Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02027896 · ClinicalTrials.gov registry record · NA
HIP Fracture Accelerated Surgical TreaTment And Care tracK (HIP ATTACK) Trial
A NA study, sponsored by McMaster University.
- Completed
- Registry status
- NA
- Development phase
- 3,001
- Enrollment target
NCT02027896 is a NA study that has completed, run by McMaster University. The registered enrollment target is 3,001 participants.
The verdict
NCT02027896, a NA study, has completed, sponsored by McMaster University.
- COMPLETED
- Registry status
- NA
- Development phase
- 3,001 participants
- Enrollment target
Study Summary
HIP ATTACK is an international randomized controlled trial of 3000 patients with a hip fracture that requires a surgical intervention. This trial will determine the effect of accelerated medical clearance and accelerated surgery compared to standard care on the 90-day risk of mortality and major perioperative complication (i.e., a composite of mortality, nonfatal myocardial infarction, nonfatal pulmonary embolism, nonfatal pneumonia, nonfatal sepsis, nonfatal stroke, and nonfatal life-threatening and major bleeding).
Interventions
- OTHER Accelerated medical clearance and surgery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,001 participants |
| Start Date | 2014-03-14 |
| Est. Completion | 2022-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02027896
The ClinicalTrials.gov registry entry for NCT02027896 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 3,001 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is McMaster University, which has 31 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Accelerated medical clearance and surgery is the first listed.
NCT02027896 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02027896 about?
NCT02027896 is a clinical study titled "HIP Fracture Accelerated Surgical TreaTment And Care tracK (HIP ATTACK) Trial". HIP ATTACK is an international randomized controlled trial of 3000 patients with a hip fracture that requires a surgical intervention. This trial will determine the effect of accelerated medical clearance and accelerated surgery compared to standard care on the 90-day risk of mortality and major per...
What is the current status of trial NCT02027896?
This trial is currently completed. It is a NA study. The enrollment target is 3,001 participants. The study started on 2014-03-14. Estimated completion is 2022-09-30.
What interventions are being tested in trial NCT02027896?
The interventions under investigation include: Accelerated medical clearance and surgery (OTHER).
Who is sponsoring clinical trial NCT02027896?
This trial is sponsored by McMaster University, which has 31 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.